Follow
COVID-19 and therapeutic management
Therapeutic management for COVID-19 infections is a rapidly evolving area and individual's must consult with a healthcare provider to determine the best course of action in their particular case. Medications such as ibuprofen and interventions such as increased hydration and rest may help mitigate symptoms and support natural immunity to quicker fight off the virus. In addition, in some cases antiviral drugs, such as Paxlovid™, may be administered to patients at high risk for severe disease.
DEC 15, 2021 | 11:00 AM
Date: December 15, 2021 Time: 11:00am (PST), 2:00pm (EST) Glassware washers (GWW) serve two important roles in today's dynamic laboratory environment. First, by automating a routine task...
NOV 17, 2021 | 8:00 AM
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
OCT 07, 2021 | 8:00 AM
Date: October 7, 2021 Time: 8:00am (PDT), 11:00am (EDT) To combat the COVID-19 pandemic, comprehensive characterization of humoral and cellular immune responses to SARS-CoV-2 is essential. A...
OCT 05, 2021 | 7:00 AM
Date: October 05, 2021 Time: 7:00am (PDT), 10:00am (EDT) After new users become familiar with flow cytometry instrumentation and learn how to set up the instrument and acquire data, the next...
JUL 15, 2021 | 10:00 AM
Date: July 15, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Sigma Metrics plays a critical role in laboratory medicine. Abbott is committed to helping your laboratory achieve excellence in clinica...
JUN 02, 2021 | 8:00 AM
Date: June 2, 2021 Time: 8:00am (PDT), 11:00am (EDT) In this introduction Kelly Hunter will address the first Learning Objective. He will cover i) a range of digital pathology and tissue mul...
APR 21, 2021 | 7:30 AM
The SARS-CoV-2 pandemic is challenging our health care systems and has profoundly impacted our society. Due to the poor global public health response, SARS-CoV-2 has developed many variants....
APR 19, 2021 | 11:15 AM
ASH Anticoagulation Guidelines in Patients with COVID-19: A moving target The American Society of Hematology (ASH) published in February 2021 “Anticoagulation Guidelines in Patients wi...
APR 01, 2021 | 8:00 AM
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
FEB 10, 2021 | 8:00 AM
Date: February 10, 2021 Time: 8:00am (PST), 11:00am (EST) Uncovering the interactions between the immune system and cancer cells or pathogens is key for understanding and controlling both ca...
NOV 12, 2020 | 12:00 AM
Cancer cells can acquire immune resistance resulting in a loss of immunosurveillance. Tumor cells can upregulate PDL-1 which binds to PD-1. This complex inhibits CD8 Tumor Infiltrating cells...
SEP 17, 2020 | 4:30 PM
T cells are the adaptive immune system’s first responders to any virus, circulating in the blood to detect and quickly multiply to attack the virus, and also support the development of...
SEP 17, 2020 | 3:30 PM
COVID-19 has developed into a crisis of global proportions. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Key to SARS-CoV-2 therapeutic development is u...
SEP 17, 2020 | 2:00 PM
Learning Objectives: 1. Understanding the integral value of collaboration for advancement in scientific research; how to establish and grow academic, Pharma, and industry connections 2. Lear...
JUL 22, 2020 | 10:00 AM
DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
JUN 30, 2020 | 10:00 AM
DATE: June 30, 2020 TIME: 10:00 am PDT, 1:00 pm EDT COVID-19 is a highly pathogenic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We have assembled a panel...
JUN 23, 2020 | 10:00 AM
DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
JUN 17, 2020 | 4:30 PM
Accelerated development of mRNA-based vaccine has necessitated the transformation of standard, research grade in vitro transcription reagents into raw material specifically designed and manu...
